Fundraising through Stock Acquisition Rights and Strengthening the Financial Base
First written in FY2016. 28 of 29 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-08-12.
12 other companies' latest entry also says "Advanced".
- 2026-08-12AdvancedEarnings
「Issuance of new shares (exercise of stock acquisition rights) 146 53 - - - 199」
The issuance of new shares upon exercise of stock acquisition rights increased capital by ¥146 million and capital surplus by ¥53 million. - FY2026AdvancedAnnual report
「Exercised during the period 1,009,850 Balance of unexercised rights at period-end 82,620 Balance exercisable at period-end 82,620」
During the consolidated fiscal year, stock acquisition rights equivalent to 1,009,850 shares were exercised, significantly advancing capital raising. The balance of unexercised rights at period-end was equivalent to 82,620 shares. - FY2026-H1AdvancedAnnual report
「1 April 2025– 30 September 2025 (Note) 1 113,200 29,968,819 123 4,818 123 4,027 (Note) 1. Resulting from the exercise of stock acquisition rights.」
113,200 shares were issued through the exercise of stock acquisition rights, increasing capital stock and capital reserve by ¥123 million each. - FY2025AdvancedAnnual report
「1 June 2024–31 March 2025 Common shares 53,210 25 4,694 25 3,903 (Note) 1. Resulting from the exercise of stock acquisition rights.」
During the consolidated fiscal year, 68,580 common shares were issued through the exercise of stock acquisition rights, increasing capital stock and capital reserve by ¥28 million each. - FY2025-H1AdvancedAnnual report
「1 April 2024–31 May 2024 (Note) 1 15,370 29,836,552 3 4,669 3 3,878 1 June 2024–30 September 2024 (Note) 1 28,300 29,830,709 19 4,689 19 3,898 (Note) 1. Resulting from the exercise of stock acquisition rights.」
During the interim consolidated accounting period, a total of 43,670 shares were issued through the exercise of stock acquisition rights, increasing capital stock and capital reserve by ¥23 million each. - FY2024AdvancedAnnual report
「1 September 2023–31 March 2024 Common shares 176,750 88 4,666 88 3,875 (Note) 1. Resulting from the exercise of stock acquisition rights.」
During the second half of the fiscal year, 176,750 common shares were issued through the exercise of stock acquisition rights, increasing capital stock and capital reserve by ¥88 million each. For the full fiscal year, 250,990 shares were exercised. - FY2024-Q3AdvancedAnnual report
「1 October 2023–31 December 2023 (Note) 7,950 29,652,382 1 4,579 1 3,789 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the third quarter of the fiscal year under review, 7,950 shares were issued through the exercise of stock acquisition rights, increasing capital stock and capital reserve by ¥1 million each. - FY2024-Q2AdvancedAnnual report
「Issuance of new shares (exercise of stock acquisition rights) 26 18 – – – 44」
During the cumulative second quarter of the fiscal year under review, the exercise of stock acquisition rights increased capital stock by ¥26 million and capital surplus by ¥18 million, and fundraising continued. - FY2023-Q3AdvancedAnnual report
「1 October 2022– 31 December 2022 Common shares 19,080 Class A preferred shares – Common shares 29,447,952 Class A preferred shares 28 4 4,489 4 3,699 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the third quarter of the fiscal year under review, 19,080 common shares were issued through the exercise of stock acquisition rights, increasing capital stock and capital reserve by ¥4 million each. - FY2023-Q2AdvancedAnnual report
「1 July 2022–30 September 2022 Common shares 89,740 Class A preferred shares – Common shares 29,428,872 Class A preferred shares 28 65 4,485 65 3,695 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the second quarter of the fiscal year under review, 89,740 common shares were issued through the exercise of stock acquisition rights, increasing capital stock and capital reserve by ¥65 million each. - FY2023-Q1AdvancedAnnual report
「1 April 2022–30 June 2022 Common shares 4,000 Class A preferred shares – (Note) Increase resulting from the exercise of stock acquisition rights.」
During the first quarter of the fiscal year under review, 4,000 common shares were issued through the exercise of stock acquisition rights, increasing capital stock and capital reserve by ¥3 million each. - FY2022AdvancedAnnual report
「1 April 2021–31 March 2022 Common shares 330,430 Common shares 29,335,132 Change in capital stock: ¥88 million Change in capital reserve: ¥88 million (Note) 1. Resulting from the exercise of stock acquisition rights.」
During the fiscal year, 330,430 common shares were issued through the exercise of stock acquisition rights, increasing capital stock and capital reserve by ¥88 million each. - FY2022-Q3AdvancedAnnual report
「1 October 2021–31 December 2021 Common shares 40,500 Class A preferred shares – Common shares 29,103,102 Class A preferred shares 28 12 4,356 12 3,566 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the third quarter of the fiscal year under review, 40,500 common shares were issued through the exercise of stock acquisition rights, increasing capital stock and capital reserve by ¥12 million each. - FY2022-Q2AdvancedAnnual report
「1 July 2021–30 September 2021 Common shares 9,400 Class A preferred shares – (Note) Increase resulting from the exercise of stock acquisition rights.」
During the second quarter of the fiscal year under review, 9,400 common shares were issued through the exercise of stock acquisition rights, increasing capital stock and capital reserve by ¥2 million each. - FY2022-Q1AdvancedAnnual report
「1 April 2021–30 June 2021 Common shares 48,500 Class A preferred shares – (Note) Increase resulting from the exercise of stock acquisition rights. At a meeting of the Board of Directors held on 30 June 2021, the Company resolved to issue the 1st Series of unsecured convertible bonds with stock acquisition rights and the 13th Series of Stock Acquisition Rights through a third-party allotment. The payment procedures for the total issue price were completed on 16 July 2021.」
During the first quarter, 48,500 common shares were issued through the exercise of stock acquisition rights. In addition, payment procedures for the convertible bonds with stock acquisition rights and the 13th Series of Stock Acquisition Rights issued through a third-party allotment were completed on 16 July 2021, giving concrete form to the fundraising. The funds will be used to repay interest-bearing debt and purchase water dispensers. - FY2021-Q3AdvancedAnnual report
「1 October 2020– 31 December 2020 Common shares 631,490 Class A preferred shares – Common shares 28,469,102 Class A preferred shares 28 122 4,227 122 3,437 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the third quarter of the fiscal year under review, 631,490 common shares were issued through the exercise of stock acquisition rights, increasing capital stock and capital reserve by ¥122 million each. - FY2021-Q2AdvancedAnnual report
「1 July 2020–30 September 2020 Common shares 204,840 Class A preferred shares – Common shares 27,837,612 Class A preferred shares 28 43 4,105 43 3,314 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the second quarter of the fiscal year under review, 204,840 common shares were issued through the exercise of stock acquisition rights, increasing capital stock and capital reserve by ¥43 million each. - FY2021-Q1AdvancedAnnual report
「1 April 2020–30 June 2020 Common shares 65,770 Class A preferred shares – Common shares 27,632,772 Class A preferred shares 28 15 4,061 15 3,271 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the first quarter of the fiscal year under review, 65,770 common shares were issued through the exercise of stock acquisition rights, increasing capital stock and capital reserve by ¥15 million each. - FY2020-Q2AdvancedAnnual report
「1 July 2019–30 September 2019 Common shares 20,670 Class A preferred shares – Common shares 27,466,832 Class A preferred shares 28 4,671 4,026,627 4,671 3,236,127 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the second quarter of the fiscal year under review, 20,670 common shares were issued through the exercise of stock acquisition rights, increasing capital stock and capital reserve by ¥4,671 thousand each. - FY2020-Q1AdvancedAnnual report
「1 April 2019–30 June 2019 Common shares 33,390 Class A preferred shares – Common shares 27,446,162 Class A preferred shares 28 7,452 4,021,956 7,452 3,131,456 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the first quarter of the fiscal year under review, 33,390 common shares were issued through the exercise of stock acquisition rights, increasing capital stock and capital reserve by ¥7,452 thousand each. - FY2019-Q3AdvancedAnnual report
「During the cumulative third quarter of the fiscal year under review, the issuance of shares through the exercise of stock acquisition rights increased capital stock and capital surplus by ¥56 million each」
The exercise of stock acquisition rights during the cumulative third quarter increased capital stock and capital surplus by ¥56 million each, advancing capital raising. - FY2019-Q1AdvancedAnnual report
「This was because the issuance of shares through the exercise of stock acquisition rights increased capital stock and capital surplus by ¥25 million each, while a quarterly net loss attributable to owners of the parent of ¥105 million was recorded.」
Stock acquisition rights were exercised during the first quarter of the fiscal year under review, increasing capital stock and capital surplus by ¥25 million each. - FY2018-Q3AdvancedAnnual report
「In addition, during the cumulative third quarter of the fiscal year under review, the exercise of stock acquisition rights increased capital stock and capital surplus by ¥119,488 thousand each. As a result, at the end of the third quarter of the fiscal year under review, capital stock was ¥3,929,075 thousand and capital surplus was ¥3,138,575 thousand.」
The exercise of stock acquisition rights during the cumulative third quarter increased capital stock and capital surplus by ¥119,488 thousand each, advancing capital raising. - FY2018-Q2AdvancedAnnual report
「The issuance of 28 Class A preferred shares pursuant to a resolution of the extraordinary general meeting of shareholders held on 27 September 2017 increased capital stock and capital surplus by ¥1,400,000 thousand each. In addition, during the cumulative second quarter of the fiscal year under review, the exercise of stock acquisition rights increased capital stock and capital surplus by ¥101,521 thousand each.」
The exercise of stock acquisition rights continued, increasing capital stock and capital surplus by ¥101,521 thousand each. In addition, capital was strengthened through the issuance of Class A preferred shares. - FY2018-Q1AdvancedAnnual report
「During the period from 1 April 2017 to 30 June 2017, the exercise of stock acquisition rights increased the total number of issued shares by 13,250 and increased capital stock and capital reserve by ¥2,524 thousand each. In addition, during the period from 1 July 2017 to 31 July 2017, the exercise of stock acquisition rights increased the total number of issued shares by 257,590 and increased capital stock and capital reserve by ¥76,073 thousand each.」
Stock acquisition rights were exercised during and after the quarter, with progress in fundraising reflected in increases in shares, capital stock and capital reserve. - FY2017-Q3AdvancedAnnual report
「The stock acquisition rights issued during the third quarter accounting period under review were as follows. (9th Series of Stock Acquisition Rights) Number of stock acquisition rights: 202,000 (Note) 1 Number of shares underlying the stock acquisition rights: 202,000 (Note) 1 Amount payable upon exercise of stock acquisition rights: ¥455 Exercise period for stock acquisition rights: 1 April 2019 to 31 March 2022」
The Company issued 202,000 of its 9th Series of Stock Acquisition Rights, with an exercise period from April 2019 to March 2022 and an exercise price of ¥455. These stock acquisition rights had not been exercised, and the disclosure does not state that funds had been raised through their exercise at this point. - FY2017-Q2AdvancedAnnual report
「During the cumulative second quarter of the fiscal year under review, capital stock and capital surplus each increased by ¥1,130,755 thousand through the exercise of stock acquisition rights. At the end of the second quarter of the fiscal year under review, capital stock was ¥2,385,631 thousand and capital surplus was ¥1,595,131 thousand.」
The exercise of stock acquisition rights increased capital stock and capital surplus by ¥1,130,755 thousand each, further giving concrete form to the raising of funds and strengthening of capital. - FY2017-Q1AdvancedAnnual report
「The Company’s 5th Series of Stock Acquisition Rights were exercised as follows during the exercise period from 4 July 2016 to 29 July 2016. Number of stock acquisition rights exercised: 4,460,572 Number of shares issued: 4,460,572 Exercise proceeds: ¥2,261,510 thousand Number of unexercised stock acquisition rights: None」
All stock acquisition rights were exercised, resulting in the raising of capital through payment of ¥2,261.51 billion and the issuance of 4,460,572 shares. - FY2016First statedAnnual report
「The Company will raise funds through a rights offering of stock acquisition rights to shareholders while simultaneously strengthening its financial base.」
In connection with the management integration, the Company used a rights offering of stock acquisition rights to shareholders as a means of raising funds and strengthening its financial base.